Laboratory tests and imaging studies in patients with cutaneous malignant melanoma
Authors:
- Nathalie ProvostNPNathalie Provost
- Ashfaq A. MarghoobAMAshfaq A. Marghoob
- Alfred W. KopfAKAlfred W. Kopf
- Ludmila LevinLLLudmila Levin
- Robert S. BartRBRobert S. Bart
- 1 September 1998
- journal article
- review article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 39 (3) , 451-463
Abstract
No abstract availableKeywords
This publication has 94 references indexed in Scilit:
- Complete remission seven years after treatment for metastatic malignant melanomaCancer, 1996
- Gastrointestinal metastases from malignant melanomaSurgical Oncology, 1995
- Technical Details of Intraoperative Lymphatic Mapping for Early Stage MelanomaArchives of Surgery, 1992
- Consensus on the management of melanoma of the skin in The NetherlandsEuropean Journal of Cancer, 1992
- Plasma 5-S-cysteinyldopa differentiates patients with primary and metastatic melanoma from patients with dysplastic nevus syndrome and normal subjectsJournal of the American Academy of Dermatology, 1988
- LDH in the follow-up of stage I malignant melanomaEuropean Journal of Cancer and Clinical Oncology, 1988
- Importance of complete cutaneous examination for the detection of malignant melanomaJournal of the American Academy of Dermatology, 1986
- Frequency and duration of patient follow-up after treatment of a primary malignant melanomaJournal of the American Academy of Dermatology, 1985
- Serum sialic acid concentrations in malignant melanomaEuropean Journal of Cancer and Clinical Oncology, 1981
- 5-S-cysteinyldopa in diagnosis and treatment of human malignant melanomas and ultrastructural observations1977